Literature DB >> 2615292

Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder.

H Christomanou1, A Chabás, T Pámpols, A Guardiola.   

Abstract

A report is presented based on the biochemical and immunochemical studies of various tissues from a 15-year-old boy with a neuronopathic form of Gaucher's disease. Qualitative and quantitative lipid analyses revealed a storage of glucosylceramide. The striking feature was that, employing the usual assay methods, a normal activity of the lysosomal enzyme glucosylceramidase was revealed, despite massive lipid accumulation. Immunochemical assays of hepatic and splenic tissue extracts from this atypical Gaucher's patient disclosed the absence of A1 activator protein, which is necessary for the enzyme degradation of glucosylceramide in vivo. This is the second documented case of a patient presenting with glucosylceramide activator protein deficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615292     DOI: 10.1007/bf01716064

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes.

Authors:  W A SKOOG; W S BECK
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

3.  Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.

Authors:  S P Peters; P Coyle; R H Glew
Journal:  Arch Biochem Biophys       Date:  1976-08       Impact factor: 4.013

4.  The precursor of sulfatide activator protein is processed to three different proteins.

Authors:  W Fürst; W Machleidt; K Sandhoff
Journal:  Biol Chem Hoppe Seyler       Date:  1988-05

5.  Infantile Gaucher's disease: A biochemical study.

Authors:  F González-Sastre; T Pampols; J Sabater
Journal:  Neurology       Date:  1974-02       Impact factor: 9.910

6.  Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.

Authors:  M W Ho; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

7.  Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.

Authors:  H Christomanou; A Aignesberger; R P Linke
Journal:  Biol Chem Hoppe Seyler       Date:  1986-09

8.  Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus.

Authors:  J S O'Brien; K A Kretz; N Dewji; D A Wenger; F Esch; A L Fluharty
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

9.  Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.

Authors:  H Christomanou
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-10

10.  Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.

Authors:  F Y Choy; R G Davidson
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

View more
  25 in total

1.  Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31.

Authors:  Geneviève Bernard; Isabelle Thiffault; Martine Tetreault; Maria Lisa Putorti; Isabelle Bouchard; Michel Sylvain; Serge Melançon; Rachel Laframboise; Pierre Langevin; Jean-Pierre Bouchard; Michel Vanasse; Adeline Vanderver; Guillaume Sébire; Bernard Brais
Journal:  Neurogenetics       Date:  2010-07-17       Impact factor: 2.660

2.  Importance of splicing for prosaposin sorting.

Authors:  L Madar-Shapiro; M Pasmanik-Chor; A M Vaccaro; T Dinur; A Dagan; S Gatt; M Horowitz
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

Review 3.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 4.  Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

Review 5.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

6.  Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.

Authors:  S Weiler; W Carson; Y Lee; D B Teplow; Y Kishimoto; J S O'Brien; J A Barranger; J M Tomich
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

7.  In silico and functional studies of the regulation of the glucocerebrosidase gene.

Authors:  Yotam N Blech-Hermoni; Shira G Ziegler; Kathleen S Hruska; Barbara K Stubblefield; Mary E Lamarca; Matthew E Portnoy; Eric D Green; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2009-11-04       Impact factor: 4.797

8.  Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids.

Authors:  Fiorella Ciaffoni; Massimo Tatti; Rosa Salvioli; Anna Maria Vaccaro
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 9.  Saposins and their interaction with lipids.

Authors:  A M Vaccaro; R Salvioli; M Tatti; F Ciaffoni
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

10.  Developmental and tissue-specific expression of prosaposin mRNA in murine tissues.

Authors:  Y Sun; D P Witte; G A Grabowski
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.